TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive Reinventing NCI: Prevention Program Lacks Leadership, Reorganization Needed, Advisory Group Says June 20, 1997